Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wagner S Brum

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Ebiomedicine|May 25, 2025
A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer's diseaseArmand González-Escalante, Marta Milà-Alomà, Wagner S Brum, et al.
JAMA Neurology|July 31, 2023
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseasePontus Erickson, Joel Simrén, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 16, 2023
Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burdenJuan Lantero-Rodriguez, Cécile Tissot, Anniina Snellman, et al.
Nature Aging|May 17, 2023
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologiesLaia Montoliu-Gaya, Andréa L Benedet, Cécile Tissot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individualsWagner S Brum, Nicholas J Ashton, Joel Simrén, et al.
Network Neuroscience (Cambridge, Mass.)|October 27, 2025
Stable brain PET metabolic networks using a multiple sampling schemeGuilherme Schu, Christian Limberger, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEduardo R Zimmer, Wyllians Vendramini Borelli, Pamela C L Ferreira, et al.
Nature Medicine|December 1, 2022
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoringNicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
The Lancet. Neurology|August 16, 2025
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisJoseph Therriault, Wagner S Brum, Lydia Trudel, et al.
Acta Neuropathologica|March 17, 2025
Biofluid-based staging of Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Nicholas J Ashton, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Ebiomedicine|May 25, 2025
A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer's diseaseArmand González-Escalante, Marta Milà-Alomà, Wagner S Brum, et al.
JAMA Neurology|July 31, 2023
Prevalence and Clinical Implications of a β-Amyloid-Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseasePontus Erickson, Joel Simrén, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 16, 2023
Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burdenJuan Lantero-Rodriguez, Cécile Tissot, Anniina Snellman, et al.
Nature Aging|May 17, 2023
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologiesLaia Montoliu-Gaya, Andréa L Benedet, Cécile Tissot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2023
Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individualsWagner S Brum, Nicholas J Ashton, Joel Simrén, et al.
Network Neuroscience (Cambridge, Mass.)|October 27, 2025
Stable brain PET metabolic networks using a multiple sampling schemeGuilherme Schu, Christian Limberger, Wagner S Brum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEduardo R Zimmer, Wyllians Vendramini Borelli, Pamela C L Ferreira, et al.
Nature Medicine|December 1, 2022
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoringNicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
The Lancet. Neurology|August 16, 2025
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisJoseph Therriault, Wagner S Brum, Lydia Trudel, et al.
Acta Neuropathologica|March 17, 2025
Biofluid-based staging of Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Nicholas J Ashton, et al.
Pageof 6